 Mohammed Maher Al-Ghannam Avalon Pharma Pharmaceuticals Sector |
● Holds a Master of Business Administration from Central California University, USA (2018). ● Holds a Bachelor of Business Administration from the University of Damascus, Syria (2009). ● Held multiple positions at Middle East Pharmaceutical Industries from 2000 to 2022. |
About the Company
Avalon Pharma achieved revenue growth of approximately 16.9% in 2025, supported by increased production capacity across its three manufacturing facilities, balanced expansion across sales channels (pharmacies and modern trade), and strong growth in both the private and government markets. Improved product mix and higher operational efficiency further supported profitability margins and overall performance. The company achieved record financial performance levels in 2025. |
|